scispace - formally typeset
D

Dubravko Jelić

Researcher at GlaxoSmithKline

Publications -  46
Citations -  1007

Dubravko Jelić is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Tyrosine kinase & In vivo. The author has an hindex of 16, co-authored 46 publications receiving 831 citations. Previous affiliations of Dubravko Jelić include Leibniz Association.

Papers
More filters
Journal ArticleDOI

Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase

TL;DR: Docking study showed that flavonoids bind to the BChE active site by forming multiple hydrogen bonds and pi-pi interactions, and UV-VIS absorption spectra of the flavonoid phosphate buffer solution revealed time dependant changes indicating precipitation of Flavonoids or in the case of myricetin, a change in the chemical structure resulting in a BChChE non-inhibiting specie.
Journal ArticleDOI

From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials.

TL;DR: A novel class of antibiotic compounds—macrolones, which are derived from macrolides and comprise macrocyclic moiety, linker, and either free or esterified quinolone 3-carboxylic group, show excellent antibacterial potency towards key erythromycin-resistant Gram-positive and Gram-negative bacterial strains, with possibly decreased potential of bacterial resistance to macrolide antibiotics.
Journal ArticleDOI

In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.

TL;DR: The potency of the oximes K048 and K027 to protect mice from five-fold LD50 oftabun and their low toxicity make these compounds leading in the therapy of tabun poisoning.
Journal ArticleDOI

Extracellular Hsp70 induces inflammation and modulates LPS/LTA-stimulated inflammatory response in THP-1 cells

TL;DR: Pro-inflammatory function of extracellular Hsp70 is confirmed, and its possible implication in COPD exacerbations caused by bacterial infection through desensitization or inappropriate activation of TLR2 and TLR4 receptors is suggested.
Journal ArticleDOI

A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers

TL;DR: The obtained protection in VX poisoning outlines its potential in development oxime-assisted OP-bioscavenging with BChE, and the cytotoxicity of lead oximes is determined, considering the strict criteria set for in vivo applications.